Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - CHANGE IN WORKING CAPITAL
Change in Working Capital RPRX - Royalty Pharma plc
3.2 B
LAST VALUE
1307.44%
2 YEAR CAGR
32.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR